Literature DB >> 11831500

Will the methamphetamine problem go away?

Richard A Rawson1, M Douglas Anglin, Walter Ling.   

Abstract

Methamphetamine use has clearly reached epidemic proportions in large parts of the western and midwestern US. Because of the regional specificity of methamphetamine use, there is speculation that it may be a temporary problem and not a long-term public health problem. Unfortunately there are a number of factors that suggest that significant methamphetamine problems may persist or even expand. For this reason, it is important that federal law enforcement, prevention, research and treatment agencies prepare strategies to address the likelihood of this persisting problem. This article reviews the issues concerning the future of the methamphetamine problem in the US and provides some recommendations for setting priorities to address the problem.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11831500     DOI: 10.1300/j069v21n01_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  40 in total

1.  Psychostimulant dependence in a community sample.

Authors:  Li-Tzy Wu; William E Schlenger
Journal:  Subst Use Misuse       Date:  2003-01       Impact factor: 2.164

2.  Demographic and practice characteristics of psychiatrists who primarily treat patients with substance use disorders.

Authors:  Ivan D Montoya; Diane M Herbeck; Dace S Svikis; Diana J Fitek; Steven C Marcus; Harold A Pincus
Journal:  Am J Addict       Date:  2003 May-Jun

Review 3.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  A comparative analysis of methamphetamine use: black gay and bisexual men in relation to men of other races.

Authors:  Perry N Halkitis; Roy C Jerome
Journal:  Addict Behav       Date:  2007-08-08       Impact factor: 3.913

6.  Substance-use outcomes at 18 months past baseline: the PROSPER Community-University Partnership Trial.

Authors:  Richard Spoth; Cleve Redmond; Chungyeol Shin; Mark Greenberg; Scott Clair; Mark Feinberg
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

7.  Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.

Authors:  Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

8.  Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.

Authors:  Chinmay K Mantri; Jyoti V Mantri; Jui Pandhare; Chandravanu Dash
Journal:  Am J Pathol       Date:  2013-10-26       Impact factor: 4.307

9.  Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.

Authors:  Shabnam Nohesara; Mohammad Ghadirivasfi; Mahmood Barati; Mohammad-Reza Ghasemzadeh; Samira Narimani; Zohreh Mousavi-Behbahani; Mohammadtaghi Joghataei; Mansoureh Soleimani; Mozhgan Taban; Soraya Mehrabi; Sam Thiagalingam; Hamid Mostafavi Abdolmaleky
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-18       Impact factor: 3.568

10.  Methamphetamine enhances HIV infection of macrophages.

Authors:  Hao Liang; Xu Wang; Hui Chen; Li Song; Li Ye; Shi-Hong Wang; Yan-Jian Wang; Lin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.